Bladder Inflammation Drug May Cause Blindness!

Elmiron, also known as pentosan polysulfate sodium (PPS), has been linked to toxic maculopathy and irreversible vision damage.

According to a paper published by Oxford University Press, “maculopathy is one of the commonest causes of blindness in the Western world.” A 2019 American Academy of Ophthalmology news release revealed that patients taking Elmiron (a drug made by Janssen Pharmaceuticals) showed clear signs of toxicity. In January 2020, the doctors published a follow-up study of over 100 ophthalmology patients. “We believe that our findings add strong support to the growing body of evidence that links long-term PPS use to the potential development of a toxic maculopathy,” the study read. Hundreds of thousands of people or more may have taken Elmiron and could be at risk of permanent vision damage. Lawsuits filed against the company allege that the manufacturer did not properly warn the public of the side effect. If you have been taking Elmiron and have suffered damage to your vision, we encourage you to take action now! Fill out this form for a free case review.

The drug came on the market in the late 1990s, and it is the only drug approved to treat pain associated with interstitial cystitis (IC). According to the National Institute of Diabetes and Digestive and Kidney Diseases, IC affects between one and four million men and three and eight million women. Also called “bladder pain syndrome,” IC is a condition that affects people with various symptoms. The symptoms can range from mild discomfort, pressure, or tenderness in the pelvic area to intense pain in the bladder, causing some to struggle with urinary urgency, the sudden need to urinate, or frequency (the need to urinate more often).